Activated eosinophils in inflammatory bowel disease: Do they matter?

American Journal of Gastroenterology

Volumn 94, Issue 12, 1999, Pages 3396-3398

  Desreumaux, P ^a   Nutten, S ^a   Colombel, J F ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGIC DISEASE; DISEASE ACTIVITY; DISEASE ASSOCIATION; EDITORIAL; ENTERITIS; EOSINOPHIL; EOSINOPHILIC GASTROENTERITIS; HISTOPATHOLOGY; HUMAN; LEUKOCYTE ACTIVATION; PRIORITY JOURNAL;

EID: 0032786258     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(99)00716-9     Document Type: Editorial

References (31)

1. Weller P.F. The immunobiology of eosinophils. N Engl J Med. 324:1991;1110-1118.
2. Filley W.V., Holley K.E., Kephart G.M., et al. Identification by immunofluorescence of eosinophil granule protein in lung tissues of patients with bronchial asthma. Lancet. 2:1982;11-16.
3. Leiferman K.M. Eosinophils in atopic dermatitis. J Allergy Clin Immunol. 94:1994;1310-1317.
4. Tai P.C., Ackerman S.J., Spry C.J., et al. Deposits of eosinophil granule proteins in cardiac tissues of patients with eosinophilic endomyocardial disease. Lancet. 1:1987;643-647.
5. Keshavarzian A., Saverymuttu S.H., Tai P.C., et al. Activated eosinophils in familial eosinophilic gastroenteritis. Gastroenterology. 88:1985;1041-1049.
6. Torpier G., Colombel J.F., Mathieu-Chandelier C., et al. Eosinophilic gastroenteritis Ultrastructural evidence for a selective release of eosinophil major basic protein . Clin Exp Immunol. 74:1988;404-408.
7. Talley N.J., Kephart G.M., McGovern T.W., et al. Deposition of eosinophil granule major basic protein in eosinophilic gastroenteritis and celiac disease. Gastroenterology. 103:1992;137-145.
8. Hallgren R., Colombel J.F., Dahl R., et al. Neutrophil and eosinophil involvement of the small bowel in patients with celiac disease and Crohn's disease Studies on the secretion rate and immunohistochemical localization of granule constituents . Am J Med. 86:1989;56-64.
9. Lavo B., Knutson L., Loof L., et al. Challenge with gliadin induces eosinophil and mast cell activation in the jejunum of patients with celiac disease. Am J Med. 87:1989;655-660.
10. Colombel J.F., Torpier G., Janin A., et al. Activated eosinophils in adult coeliac disease Evidence for a local release of major basic protein . Gut. 33:1992;1190-1194.
11. Furuta G.T., Ackerman S.J., Wershil B.K. The role of the eosinophil in gastrointestinal diseases. Cur Opin Gastroenterol. 11:1995;541-547.
12. Levy A.M., Kita K. The eosinophil in gut inflammation Effector or director? Gastroenterology. 110:1996;952-954.
13. Heatley R.V., James P.D. Eosinophils in the rectal mucosa. A simple method of predicting the outcome of ulcerative proctocolitis. Gut. 20:1978;787-791.
14. Bischoff S.C., Wedemeyer J., Herrmann A., et al. Quantitative assessment of intestinal eosinophils and mast cells in inflammatory bowel disease. Histopathology. 28:1996;1-13.
15. Raab Y., Fredens K., Gerdin B., et al. Eosinophil activation in ulcerative colitis. Dig Dis Sci. 43:1998;1061-1070.
16. Dvorak A.M. Ultrastructural evidence for release of major basic protein-containing crystalline cores of eosinophil granules in vivo Cytotoxic potential in Crohn's disease . J Immunol. 125:1980;460-462.
17. Dubucquoi S., Janin A., Desreumaux P., et al. Activated eosinophils and IL-5 expression in early recurrent Crohn's disease. Gut. 37:1995;242-246.
18. Levy A.M., Gleich G.J., Sandborn W.J., et al. Increased eosinophil granule proteins in gut lavage fluid from patients with inflammatory bowel disease. Mayo Clin Proc. 72:1997;117-123.
19. Berstad A., Borkje B., Riedel B., et al. Increased fecal eosinophil cationic protein in inflammatory bowel disease. Hepatogastroenterology. 40:1993;276-278.
20. Bischoff S.C., Grabowsky J., Manns M.P. Quantification of inflammatory mediators in stool samples of patients with inflammatory bowel disorders and controls. Dig Dis Sci. 42:1997;394-403.
21. Saitoh O., Kojima K., Sugi K., et al. Fecal eosinophil granule-derived proteins reflect disease activity in inflammatory bowel disease. Am J Gastroenterol. 94:1999;3513-3520.
22. Bischoff S.C., Mayer J., Nguyen Q.-T., et al. Immunohistological assessment of intestinal eosinophil activation in patients with eosinophilic gastroenteritis and inflammatory bowel disease. Am J Gastroenterol. 94:1999;3521-3529.
23. Ferguson A., Humphreys K.A., Croft N.M. Technical report Results of immunological tests on faecal extracts are likely to be extremely misleading . Clin Exp Immunol. 99:1995;70-75.
24. Desreumaux P., Capron M. Eosinophils in allergic reactions. Cur Opin Immunol. 8:1996;790-795.
25. Lamas A.M., Leon O.G., Schleimer R.P. Glucocorticoids inhibit eosinophil responses to granulocyte-macrophage colony-stimulating factor. J Immunol. 147:1991;254-259.
26. Wyatt J., Vogelsang H., Hubl W., et al. Intestinal permeability and the prediction of relapse in Crohn's disease. Lancet. 341:1993;1437-1439.
27. Schreiber S., Nikolaus S., Hampe J., et al. Tumour necrosis factor alpha and interleukin 1 beta in relapse of Crohn's disease. Lancet. 353:1999;459-461.
28. Grewe M., Bruijnzeel-Koomen C.A., Schopf E., et al. A role for Th1 and Th2 cells in the immunopathogenesis of atopic dermatitis. Immunol Today. 19:1998;359-361.
29. Desreumaux P., Brandt E., Gambiez L., et al. Distinct cytokines patterns in early and chronic ileal lesions of Crohn's disease. Gastroenterology. 113:1997;118-126.
30. Boirivant M., Fuss I., Chu A., et al. Oxazolone colitis A murine model of T helper type 2 colitis treatable with antibodies to interleukin-4 . J Exp Med. 16:1998;1929-1939.
31. Takahashi I., Kiyono H., Hamada S. CD4+ T-cell population mediates development of inflammatory bowel disease in T-cell receptor α chain-deficient mice. Gastroenterology. 112:1997;1876-1886.